BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 8:24:11 AM | Browse: 8 | Download: 15
Publication Name World Journal of Clinical Cases
Manuscript ID 64483
Country/Territory China
Received
2021-03-13 16:42
Peer-Review Started
2021-02-19 09:13
To Make the First Decision
Return for Revision
2021-04-04 16:07
Revised
2021-04-17 02:19
Second Decision
2021-05-24 06:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-05-24 10:23
Articles in Press
2021-05-24 10:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-06-06 08:48
Typeset the Manuscript
2021-07-12 17:02
Publish the Manuscript Online
2021-07-21 08:24
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Relapsed/refractory classical Hodgkin lymphoma effectively treated by combination low-dose decitabine plus tislelizumab: A case report
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Sheng Ding, Lan Mi, Yu-Qin Song, Wei-Ping Liu, Hui Yu, Ning-Jing Lin and Jun Zhu
ORCID
Author(s) ORCID Number
Xiao-Sheng Ding http://orcid.org/0000-0003-0667-6303
Lan Mi http://orcid.org/0000-0003-2618-1906
Yu-Qin Song http://orcid.org/0000-0001-5451-6481
Wei-Ping Liu http://orcid.org/0000-0002-0367-1411
Hui Yu http://orcid.org/0000-0003-1308-4832
Ning-Jing Lin http://orcid.org/0000-0002-4292-8179
Jun Zhu http://orcid.org/0000-0003-3479-2547
Funding Agency and Grant Number
Corresponding Author Jun Zhu, MD, PhD, Chief Doctor, Doctor, Professor, Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. zhu-jun2017@outlook.com
Key Words Immunotherapy; Hypomethylating agent; Classical Hodgkin lymphoma; Survival; Case report
Core Tip We report a 27-year-old man who complained of enlarged right-sided cervical lymph nodes and progressive pain aggravation of the right shoulder over the past 3 mo before admission. Histological analysis of lymph node biopsy was suggestive of classical Hodgkin’s lymphoma. The patient experienced failure of eight lines of therapy. Computed tomography showed that the tumors of the chest and abdomen significantly shrunk or disappeared after 3 cycles of treatment. The patient has been followed up for 11.5 mo until now, and no progressive enlargement of the tumor has been observed.
Publish Date 2021-07-21 08:24
Citation Ding XS, Mi L, Song YQ, Liu WP, Yu H, Lin NJ, Zhu J. Relapsed/refractory classical Hodgkin lymphoma effectively treated by combination low-dose decitabine plus tislelizumab: A case report. World J Clin Cases 2021; 9(21): 6041-6048
URL https://www.wjgnet.com/2307-8960/full/v9/i21/6041.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i21.6041
Full Article (PDF) WJCC-9-6041.pdf
Full Article (Word) WJCC-9-6041.docx
Manuscript File 64483_Auto_Edited-JPY_WangTQ.docx
Answering Reviewers 64483-Answering reviewers.pdf
Audio Core Tip 64483-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 64483-Conflict-of-interest statement.pdf
Copyright License Agreement 64483-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 64483-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 64483-Language certificate.pdf
Peer-review Report 64483-Peer-review(s).pdf
Scientific Misconduct Check 64483-Bing-Wan JL-1.jpg
Scientific Misconduct Check 64483-CrossCheck.png
Scientific Misconduct Check 64483-Bing-Gong ZM-2.png
Scientific Misconduct Check 64483-Scientific misconduct check.pdf
Scientific Editor Work List 64483-Scientific editor work list.pdf